Researchers from the HUN-REN Szeged Biological Research Centre and HCEMM have just published a new study suggesting that it's not simply the number of tumor mutations that matters for immunotherapy, ...
Mapping diverse mutations within a cancer hotspot revealed that distinct variants drive tumor growth to different extents, which could guide anticancer therapies.
The US Food and Drug Administration (FDA) today approved the first blood-based genetic test that can detect epidermal growth factor receptor (EGFR) gene mutations in non-small cell lung cancer ...
CLDN18.2 IHC cutoff and efficacy of anti-CLDN18.2 therapy in gastric and gastroesophageal junction adenocarcinoma: A systematic review and meta-analysis. Selected genomic alterations in TP53 Y220C+ vs ...
Cancer cells carry thousands of mutations, but not all mutations are created equal. Some make tumors highly visible to the ...